Literature DB >> 23357243

Coronary artery dimensions in febrile children without Kawasaki disease.

Juan-Carlos G Muniz1, Kirsten Dummer, Kimberlee Gauvreau, Steven D Colan, David R Fulton, Jane W Newburger.   

Abstract

BACKGROUND: Coronary artery (CA) dilatation on echocardiography is a criterion for treatment with intravenous immunoglobulin for incomplete Kawasaki disease (KD). However, CA dimensions for febrile children are unknown. We compared CA dimensions in children with febrile illnesses other than KD to those of normal afebrile children and to KD patients. METHODS AND
RESULTS: We performed echocardiograms in 43 patients who met the following inclusion criteria: (1) age 3 months to 18 years, (2) daily fever >38°C for ≥96 hours, and (3) a diagnosis other than KD. These subjects had mean CA z scores greater than normative values (left main CA=0.66±0.75, P<0.001; right CA=0.28±0.81, P=0.03; left anterior descending CA=0.35±1.0, P=0.03). Maximum CA z score >2 was found in 2 subjects (osteomyelitis, Mycoplasma pneumonia). Among demographic and laboratory measures, only higher platelet count was associated with greater left anterior descending CA z scores (P=0.004) and maximum CA z score (P=0.03). Non-KD febrile subjects, compared with 144 KD patients, had smaller CA z scores (P=0.04, P<0.001, and P<0.001 for left main CA, right CA, and left anterior descending CA, respectively), and lower white blood cell count, erythrocyte sedimentation rate, and platelet count (all P<0.001). A maximum CA z score cutoff of 2.0 had specificity of 95% (95% confidence interval, 84%-99%) and sensitivity of 32% (95% confidence interval, 25%-41%) in distinguishing non-KD febrile from KD patients; for maximum CA z score of 2.5, specificity was 98% and sensitivity was 20%.
CONCLUSIONS: This pilot study found that mean CA dimensions in children with non-KD febrile illnesses are larger than those in normative afebrile subjects but smaller than dimensions in patients with KD. Future studies should augment the available data on CA dimensions in children with more severe febrile illnesses.

Entities:  

Mesh:

Year:  2013        PMID: 23357243     DOI: 10.1161/CIRCIMAGING.112.000159

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  25 in total

1.  Giant Coronary Aneurysms in a one-month-old Infant with Kawasaki Disease.

Authors:  Ji Hoon Kim; Minchae Kim; Jin-Hee Oh; Jae Young Lee; Kyung Yil Lee; Dae Kyun Koh
Journal:  Indian J Pediatr       Date:  2016-09-19       Impact factor: 1.967

Review 2.  Immune pathogenesis of COVID-19-related multisystem inflammatory syndrome in children.

Authors:  Anne H Rowley; Stanford T Shulman; Moshe Arditi
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

3.  Differences in Sensitivity Between the Japanese and Z Score Criteria for Detecting Coronary Artery Abnormalities Resulting from Kawasaki Disease.

Authors:  Ryusuke Ae; Yoshihide Shibata; Tohru Kobayashi; Koki Kosami; Masanari Kuwabara; Nobuko Makino; Yuri Matsubara; Teppei Sasahara; Hiroya Masuda; Yosikazu Nakamura
Journal:  Pediatr Cardiol       Date:  2022-09-19       Impact factor: 1.838

4.  Medium-Term Cardiac Outcomes in Young People with Multi-system Inflammatory Syndrome: The Era of COVID-19.

Authors:  James Wong; Paraskevi Theocharis; William Regan; Kuberan Pushparajah; Natasha Stephenson; Emma Pascall; Aoife Cleary; Laura O'Byrne; Alex Savis; Owen Miller
Journal:  Pediatr Cardiol       Date:  2022-04-29       Impact factor: 1.838

Review 5.  The Complexities of the Diagnosis and Management of Kawasaki Disease.

Authors:  Anne H Rowley
Journal:  Infect Dis Clin North Am       Date:  2015-07-04       Impact factor: 5.982

6.  Inflammation aggravates heterogeneity of ventricular repolarization in children with Kawasaki disease.

Authors:  Masayuki Fujino; Tadayoshi Hata; Marina Kuriki; Kayo Horio; Hidetoshi Uchida; Yoshihiko Eryu; Hiroko Boda; Masafumi Miyata; Tetsushi Yoshikawa
Journal:  Pediatr Cardiol       Date:  2014-05-14       Impact factor: 1.655

7.  Prediction of intravenous immunoglobulin resistance in patients with Kawasaki disease according to the duration of illness prior to treatment.

Authors:  Kee-Soo Ha; JungHwa Lee; Kwang Chul Lee
Journal:  Eur J Pediatr       Date:  2019-11-12       Impact factor: 3.183

8.  Coronary Artery Dilatation in Viral Myocarditis Mimics Coronary Artery Findings in Kawasaki Disease.

Authors:  Soha Rached-D'Astous; Ibtissama Boukas; Anne Fournier; Marie-Josée Raboisson; Nagib Dahdah
Journal:  Pediatr Cardiol       Date:  2016-05-27       Impact factor: 1.838

9.  Safety netting versus overtreatment in paediatrics: viral infection or incomplete Kawasaki disease?

Authors:  Jennifer Michelle Charlesworth; Bernadette Power; Edina Moylett
Journal:  BMJ Case Rep       Date:  2017-11-08

10.  Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease.

Authors:  Adriana H Tremoulet; Janusz Dutkowski; Yuichiro Sato; John T Kanegaye; Xuefeng B Ling; Jane C Burns
Journal:  Pediatr Res       Date:  2015-08-03       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.